Followers | 4054 |
Posts | 152184 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Tuesday, April 23, 2019 9:48:33 AM
IMUX
Recent IMUX News
- Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis • PR Newswire (US) • 09/18/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 08:05:53 PM
- Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome • PR Newswire (US) • 09/04/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:30:38 PM
- Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September • PR Newswire (US) • 08/28/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:17:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:45:40 AM
- Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 08/08/2024 10:30:00 AM
- Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update • PR Newswire (US) • 08/01/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:11:28 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:10:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 10:40:20 AM
- Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec • PR Newswire (US) • 07/24/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 12:31:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 10:40:33 AM
- Immunic Appoints Jason Tardio as Chief Operating Officer and President • PR Newswire (US) • 07/09/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:07:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:05:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/10/2024 08:05:34 PM
- Immunic to Participate in Industry and Scientific Conferences in June • PR Newswire (US) • 05/28/2024 10:30:00 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/24/2024 08:06:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:20:20 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM